Status
ACTIVE
Global HQ
North Chicago, USA
Countries of investment
- USA
- United Kingdom
- Germany
- France
- Italy
- Netherlands
- Switzerland
Investment stages
- Pre-Seed
- Seed
Industries
- Life Sciences
About
AbbVie Ventures is the strategic venture capital arm of AbbVie, investing in early and late-stage biotech companies. It focuses on advancing innovative therapies and technologies aligned with AbbVie’s therapeutic areas to accelerate drug development and commercialization. (Note: Limited specific details from current search results.)
AbbVie Ventures is the strategic venture capital arm of AbbVie, investing in early and late-stage biotech companies. It focuses on advancing innovative therapies and technologies aligned with AbbVie’s therapeutic areas to accelerate drug development and commercialization. (Note: Limited specific details from current search results.)
Investment Thesis
AbbVie Ventures is a corporate venture capital fund investing in innovative healthcare and biotechnology companies worldwide, focusing on novel therapeutics and treatments addressing unmet patient needs.
Manager's Experience
AbbVie Ventures invests strategically alongside partners to advance innovative biopharmaceutical therapies, leveraging AbbVie's scientific expertise and extensive resources to support healthcare and life sciences startups.
Team
Christian Schubert – Investment Team
Doug Faunce – Investment Team
Shawna Frazier – Investment Team
Donmienne Leung – Investment Team
Claire Leurent – Investment Team
Danjuma Quarless – Investment Team
Christina Vorvis – Investment Team
Shann Yu – Investment Team
Joachim Vogt – Investment Team